HomeCompareIVRO vs YUM

IVRO vs YUM: Dividend Comparison 2026

IVRO yields 2247.19% · YUM yields 1.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IVRO wins by $29547769702.70M in total portfolio value
10 years
IVRO
IVRO
● Live price
2247.19%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29547769702.81M
Annual income
$27,169,407,696,231,896.00
Full IVRO calculator →
YUM
YUM
● Live price
1.85%
Share price
$155.48
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.0K
Annual income
$39,957.33
Full YUM calculator →

Portfolio growth — IVRO vs YUM

📍 IVRO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIVROYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IVRO + YUM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IVRO pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IVRO
Annual income on $10K today (after 15% tax)
$191,011.24/yr
After 10yr DRIP, annual income (after tax)
$23,093,996,541,797,110.00/yr
YUM
Annual income on $10K today (after 15% tax)
$157.45/yr
After 10yr DRIP, annual income (after tax)
$33,963.73/yr
At 15% tax rate, IVRO beats the other by $23,093,996,541,763,148.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IVRO + YUM for your $10,000?

IVRO: 50%YUM: 50%
100% YUM50/50100% IVRO
Portfolio after 10yr
$14773884851.46M
Annual income
$13,584,703,848,135,926.00/yr
Blended yield
91.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

IVRO
No analyst data
Altman Z
5.8
Piotroski
5/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+11.4% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IVRO buys
0
YUM buys
0
No recent congressional trades found for IVRO or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIVROYUM
Forward yield2247.19%1.85%
Annual dividend / share$2.00$2.88
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.4%
Portfolio after 10y$29547769702.81M$107.0K
Annual income after 10y$27,169,407,696,231,896.00$39,957.33
Total dividends collected$29380400700.81M$80.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: IVRO vs YUM ($10,000, DRIP)

YearIVRO PortfolioIVRO Income/yrYUM PortfolioYUM Income/yrGap
1← crossover$235,419$224,719.10$10,980$280.44+$224.4KIVRO
2$5,196,120$4,944,221.38$12,185$435.72+$5.18MIVRO
3$107,548,439$101,988,590.74$13,722$684.14+$107.53MIVRO
4$2,087,920,928$1,972,844,098.40$15,773$1,090.14+$2087.91MIVRO
5$38,028,791,779$35,794,716,385.74$18,650$1,773.02+$38028.77MIVRO
6$649,994,244,523$609,303,437,319.89$22,921$2,966.37+$649994.22MIVRO
7$10,428,496,321,719$9,733,002,480,079.00$29,685$5,158.69+$10428496.29MIVRO
8$157,098,792,021,426$145,940,300,957,186.47$41,216$9,453.02+$157098791.98MIVRO
9$2,222,768,230,443,579$2,054,672,522,980,653.50$62,672$18,571.31+$2222768230.38MIVRO
10$29,547,769,702,806,524$27,169,407,696,231,896.00$107,016$39,957.33+$29547769702.70MIVRO

IVRO vs YUM: Complete Analysis 2026

IVROStock

InVitro International develops test kits for non-animal testing in the United States and internationally. Its products include Irritection Assay System, an invitro test, which could be used to detect, rank, and predict the ocular and/or dermal irritation potential of cosmetics, consumer products, pharmaceuticals, and chemical raw materials; and Corrositex, an invitro test that determines chemical corrosivity. The company also provides customized technology services for Irritection Assay System installation and testing process, as well as independent testing laboratory services for irritancy and corrosivity testing requirements. Its products are principally used by the manufacturers of surfactants, petrochemicals, cosmetics, textiles, paper and pulp, pharmaceuticals, films and resins, solvents and cleaners, and other chemical raw materials. The company was founded in 1985 and is headquartered in Placentia, California.

Full IVRO Calculator →

YUMConsumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this IVRO vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IVRO vs SCHDIVRO vs JEPIIVRO vs OIVRO vs KOIVRO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.